Literature DB >> 17258114

Coagulation 2006: a modern view of hemostasis.

Maureane Hoffman1, Dougald M Monroe.   

Abstract

The authors propose that hemostasis occurs in a stepwise process, regulated by cellular components in vivo. The effectiveness of hemostasis in vivo depends not only on the procoagulant reactions but also on the fibrinolytic process. Causes of coagulopathic bleeding include consumption of coagulation factors and platelets, excessive fibrinolysis, hypothermia, and acidosis. Generation of the right amount of thrombin during the coagulation process not only may be essential for effective hemostasis but also may set the stage for effective wound healing.

Entities:  

Mesh:

Year:  2007        PMID: 17258114     DOI: 10.1016/j.hoc.2006.11.004

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  43 in total

1.  Successful use of a military haemostatic agent in patients undergoing extracorporeal circulatory assistance and delayed sternal closure.

Authors:  Luigi Muzzi; Giulio Tommasino; Enrico Tucci; Eugenio Neri
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-24

Review 2.  Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin.

Authors:  Qudsia Rashid; Poonam Singh; Mohammad Abid; Mohamad Aman Jairajpuri
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

3.  Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.

Authors:  Joanna L Sylman; Annachiara Mitrugno; Garth W Tormoen; Todd H Wagner; Parag Mallick; Owen J T McCarty
Journal:  Converg Sci Phys Oncol       Date:  2017-05-17

4.  Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy.

Authors:  Dominik R Weiss; Gerd Juchem; Bernhard M Kemkes; Brigitte Gansera; Stephan Nees
Journal:  Int J Clin Exp Med       Date:  2009-05-28

5.  Kinetic model facilitates analysis of fibrin generation and its modulation by clotting factors: implications for hemostasis-enhancing therapies.

Authors:  Alexander Y Mitrophanov; Alisa S Wolberg; Jaques Reifman
Journal:  Mol Biosyst       Date:  2014-07-29

6.  Thromboelastographic changes after gonadectomy in retired racing greyhounds.

Authors:  P Vilar Saavedra; N Stingle; C Iazbik; L Marín; M A McLoughlin; Y Xie; G Couto
Journal:  Vet Rec       Date:  2011-07-01       Impact factor: 2.695

Review 7.  Monitoring target specific anticoagulants.

Authors:  Barbara A Konkle
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

Review 8.  Fibrinolysis in trauma: a review.

Authors:  M J Madurska; K A Sachse; J O Jansen; T E Rasmussen; J J Morrison
Journal:  Eur J Trauma Emerg Surg       Date:  2017-09-16       Impact factor: 3.693

9.  Trauma hemostasis and oxygenation research position paper on remote damage control resuscitation: definitions, current practice, and knowledge gaps.

Authors:  Donald H Jenkins; Joseph F Rappold; John F Badloe; Olle Berséus; Lorne Blackbourne; Karim H Brohi; Frank K Butler; Andrew P Cap; Mitchell Jay Cohen; Ross Davenport; Marc DePasquale; Heidi Doughty; Elon Glassberg; Tor Hervig; Timothy J Hooper; Rosemary Kozar; Marc Maegele; Ernest E Moore; Alan Murdock; Paul M Ness; Shibani Pati; Todd Rasmussen; Anne Sailliol; Martin A Schreiber; Geir Arne Sunde; Leo M G van de Watering; Kevin R Ward; Richard B Weiskopf; Nathan J White; Geir Strandenes; Philip C Spinella
Journal:  Shock       Date:  2014-05       Impact factor: 3.454

10.  Blood flow controls coagulation onset via the positive feedback of factor VII activation by factor Xa.

Authors:  Alexey M Shibeko; Ekaterina S Lobanova; Mikhail A Panteleev; Fazoil I Ataullakhanov
Journal:  BMC Syst Biol       Date:  2010-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.